Global Biologic Imaging Reagents Market Size, Share And Growth Analysis For 2024-2033

(MENAFN- EIN Presswire)

Biologic Imaging Reagents Global market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

The Business Research Company's Biologic Imaging Reagents Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

You Can Now Pre Order Your Report To Get A Swift Deliver With All Your Needs” - The Business research company

LONDON, GREATER LONDON, UK, July 11, 2024 /EINPresswire / -- The biologic imaging reagents market has experienced robust growth in recent years, expanding from $16.69 billion in 2023 to $18.41 billion in 2024 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to rise in prevalence of chronic diseases, growing research and development investments, shift towards personalized medicine, focus on early disease detection, increasing geriatric population, collaborations in biomedical research.

Strong Future Growth Anticipated
The biologic imaging reagents market is projected to continue its strong growth, reaching $25.72 billion in 2028 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to expanding applications in drug development, rising demand for molecular imaging, focus on non-invasive diagnostic methods, global increase in cancer cases, shift towards value-based healthcare. Major trends in the forecast period include rise in demand for contrast-enhanced imaging agents, development of targeted molecular imaging agents, application of nanoparticles in imaging, emergence of fluorescent probes for in vivo imaging, integration of artificial intelligence in image analysis.

Explore Comprehensive Insights Into The Global Biologic Imaging Reagents Market With A Detailed Sample Report:

Growth Driver Of The Biologic Imaging Reagents Market
The increase in the prevalence of chronic diseases is expected to propel the growth of the biologic imaging reagents market going forward. Chronic diseases refer to conditions that last one year or longer and require continuous medical attention, which may worsen over time. Chronic diseases require biologic imaging reagents to diagnose and detect diseases by visualizing organs and affected structures.

Explore The Report Store To Make A Direct Purchase Of The Report:

Major Players And Market Trends
Key players in the biologic imaging reagents market include Cardinal Health Inc., Johnson And Johnson Services Inc., Bayer Healthcare AG, Thermo Fisher Scientific Inc., Siemens Healthcare GmbH, Dickinson and Company (BD), Koninklijke Philips N.V., GE HealthCare Technologies Inc., Stryker Corporation, FluoroPharma Medical Inc., Lonza Group AG, Illumina Inc., PerkinElmer Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Bracco Diagnostics Inc., Leica Microsystems GmbH, Lantheus Medical Imaging Inc., Guerbet SA, Miltenyi Biotec B.V. and Co. KG, Promega Corporation, Abcam plc., Luminex Corporation, MILabs, LI-COR Biosciences, FUJIFILM VisualSonics Inc., Advanced Proteome Therapeutics Incorporated, BIOPRO Baden-Württemberg GmbH, ABX Advanced Biochemical Compounds GmbH.

Major companies operating in the biologic imaging reagents market are focusing on developing innovative reagents, such as novel dye technology, offering researchers and clinicians a new tool for visualizing and improving the sensitivity and specificity of biologic imaging. Novel dye technology refers to developing new dyes for various applications, including biological imaging.

Biologic Imaging Reagents Market Segments :
1) By Product: Contrast Reagents, Optical Imaging Reagents, Radiopharmaceuticals
2) By Modality: Magnetic Resonance Imaging (MRI), Ultrasound, X-Ray And Computerized Tomography (CT), Nuclear, Optical Imaging, Other Modalities
3) By Application: In Vitro, In Vivo
4) By End User: Diagnostic Laboratories, Imaging Centers, Life Science Companies, Research And Academic Institutes, Other End Users

Geographical Insights: North America Leading The Market
North America was the largest region in the biologic imaging reagents market in 2023. Asia-Pacific is expected to be the fastest-growing region during the forecast period, driven by expanding healthcare facilities and increasing awareness of the benefits of biologic imaging reagents.

Biologic Imaging Reagents Market Definition
Biologic imaging reagents refer to substances or compounds that are used in various imaging techniques to enhance the visibility and contrast of biological structures, molecules, or processes. These reagents are designed to interact specifically with specific biological targets, such as proteins, nucleic acids, or cellular structures, to make them more visible and distinguishable during imaging.

Biologic Imaging Reagents Global Market Report 2024 from THE BUSINESS RESEARCH COMPANY covers the following information:
.Market size data for the forecast period: Historical and Future
.Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
.Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.

The Biologic Imaging Reagents Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on biologic imaging reagents market size, biologic imaging reagents market drivers and trends, biologic imaging reagents market major players, biologic imaging reagents competitors' revenues, biologic imaging reagents market positioning, and biologic imaging reagents market growth across geographies. The biologic imaging reagents market report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:

Bioinformatics Global Market Report 2024

Biophotonics Global Market Report 2024

Bioabsorbable Stents Global Market Report 2024

About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company's flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
Visit us on social media:


EIN Presswire

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.